William Blair initiated coverage on shares of Savers Value Village (NYSE:SVV – Free Report) in a research note issued to investors on Friday morning, MarketBeat reports. The brokerage issued an ...

As of March 19, 2025, the average one-year price target for Immunic is $13.43/share. The forecasts range from a low of $5.05 to a high of $29.40. The average price target represents an increase of ...

On Thursday, William Blair initiated coverage on Mersana Therapeutics, Inc. (NASDAQ:MRSN) with an Outperform rating. The firm's analyst cited the company's potential in the antibody-drug ...

On Thursday, William Blair initiated coverage on Waste Connections Inc . (NYSE:WCN) with an Outperform rating, signaling confidence in the company’s growth potential. The company, currently ...

Fintel reports that on February 28, 2025, William Blair initiated coverage of Corbus Pharmaceuticals Holdings (LSE:0SZI) with a Outperform recommendation. There are 220 funds or institutions ...

Investing.com -- William Blair raised DocuSign (NASDAQ:DOCU) to Outperform in a note Monday, highlighting optimism around the company’s Intelligent Agreement Management (IAM) platform and its ...

On Monday, Butterfly Network, Inc. (NYSE:BFLY) received a new stock rating from William Blair, commencing coverage with an Outperform rating. The research firm highlighted the company’s ...

Research analysts at William Blair initiated coverage on shares of Immunic (NASDAQ:IMUX – Get Free Report) in a research note issued to investors on Tuesday, Marketbeat.com reports. The brokerage set ...